HomeBUSINESS
BUSINESS

Shionogi’s Sakigake-Designated Flu Med Shows Efficacy in Japan PII
(Aug.30.2016)

Shionogi said on August 29 that S-033188, the company’s investigational anti-influenza drug designated for the sakigake fast-track pathway, has demonstrated significantly better vial load reductions compared to placebo in a PII trial ...
(LOG IN FOR FULL STORY)